Ana Cristina Rego
#168,768
Most Influential Person Now
Portuguese neuroscientist
Ana Cristina Rego's AcademicInfluence.com Rankings
Ana Cristina Regobiology Degrees
Biology
#14178
World Rank
#17869
Historical Rank
Neuroscience
#2601
World Rank
#2671
Historical Rank
Download Badge
Biology
Ana Cristina Rego's Degrees
- Bachelors Biology University of Lisbon
- Masters Neuroscience University of Porto
- PhD Neuroscience University of Coimbra
Similar Degrees You Can Earn
Why Is Ana Cristina Rego Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ana Cristina Rego is a Portuguese neurologist. She is a professor at the University of Coimbra in Portugal and is head of the research group on Mitochondria and Neurodegenerative disorders, researching on topics such as Alzheimer’s disease, Huntingdon's disease, and Parkinson’s disease. She is presently president of the Portuguese Society of Neuroscience.
Ana Cristina Rego's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mitochondrial Dysfunction and Reactive Oxygen Species in Excitotoxicity and Apoptosis: Implications for the Pathogenesis of Neurodegenerative Diseases (2003) (437)
- Mechanisms of neurodegeneration in Huntington’s disease (2008) (424)
- Mitochondrial Membrane Potential and Glutamate Excitotoxicity in Cultured Cerebellar Granule Cells (2000) (310)
- Cellular and molecular mechanisms involved in the neurotoxicity of opioid and psychostimulant drugs (2008) (184)
- An integrative view of the role of oxidative stress, mitochondria and insulin in Alzheimer's disease. (2009) (165)
- Dysfunctional synapse in Alzheimer's disease – A focus on NMDA receptors (2014) (158)
- Mitochondrial dysfunction in Huntington’s disease: the bioenergetics of isolated and in situ mitochondria from transgenic mice (2007) (147)
- Amyloid beta peptide 1-42 disturbs intracellular calcium homeostasis through activation of GluN2B-containing N-methyl-d-aspartate receptors in cortical cultures. (2012) (145)
- Oxidative stress involving changes in Nrf2 and ER stress in early stages of Alzheimer's disease. (2015) (143)
- Multiple Defects in Energy Metabolism in Alzheimers Disease (2010) (139)
- Mitochondrial- and Endoplasmic Reticulum-Associated Oxidative Stress in Alzheimer's Disease: From Pathogenesis to Biomarkers (2012) (138)
- Insulin neuroprotection against oxidative stress is mediated by Akt and GSK-3beta signaling pathways and changes in protein expression. (2008) (133)
- Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse. (2012) (130)
- Mitochondrial-Dependent Ca2+ Handling in Huntington's Disease Striatal Cells: Effect of Histone Deacetylase Inhibitors (2006) (129)
- Multiple defects in energy metabolism in Alzheimer's disease. (2010) (119)
- Shaping the Nrf2-ARE-related pathways in Alzheimer’s and Parkinson’s diseases (2019) (118)
- Mitochondrial dysfunction and caspase activation in rat cortical neurons treated with cocaine or amphetamine (2006) (113)
- Nuclear localization and phosphorylation modulate pathological effects of alpha‐synuclein (2018) (112)
- Oxidative Stress, Hypoxia, and Ischemia‐Like Conditions Increase the Release of Endogenous Amino Acids by Distinct Mechanisms in Cultured Retinal Cells (1996) (111)
- Mitochondrial Dysfunction in Huntington's Disease. (2018) (108)
- Antioxidant effect of flavonoids after ascorbate/Fe(2+)-induced oxidative stress in cultured retinal cells. (2001) (108)
- Effect of amyloid β‐peptide on permeability transition pore: A comparative study (2002) (106)
- Cytosolic and mitochondrial ROS in staurosporine-induced retinal cell apoptosis. (2003) (106)
- Insulin and IGF-1 improve mitochondrial function in a PI-3K/Akt-dependent manner and reduce mitochondrial generation of reactive oxygen species in Huntington's disease knock-in striatal cells. (2014) (101)
- Sodium butyrate rescues dopaminergic cells from alpha-synuclein-induced transcriptional deregulation and DNA damage (2017) (98)
- Toxic Effects of Opioid and Stimulant Drugs on Undifferentiated PC12 Cells (2002) (95)
- Insulin Restores Metabolic Function in Cultured Cortical Neurons Subjected to Oxidative Stress (2006) (92)
- Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N‐methyl‐D‐aspartate receptor in mature hippocampal cultures treated with amyloid‐β oligomers (2012) (91)
- Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models (2017) (90)
- Revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease--resemblance to the effect of amphetamine drugs of abuse. (2012) (88)
- The mechanism of mitochondrial membrane potential retention following release of cytochrome c in apoptotic GT1-7 neural cells (2001) (86)
- Linking alpha-synuclein phosphorylation to reactive oxygen species formation and mitochondrial dysfunction in SH-SY5Y cells (2014) (84)
- Street heroin induces mitochondrial dysfunction and apoptosis in rat cortical neurons (2007) (83)
- Insulin neuroprotection against oxidative stress in cortical neurons--involvement of uric acid and glutathione antioxidant defenses. (2005) (78)
- Effect of amyloid beta-peptide on permeability transition pore: a comparative study. (2002) (76)
- The R6 lines of transgenic mice: A model for screening new therapies for Huntington's disease (2009) (68)
- Evidence of apoptosis and mitochondrial abnormalities in peripheral blood cells of Huntington's disease patients. (2008) (68)
- FK506 prevents mitochondrial-dependent apoptotic cell death induced by 3-nitropropionic acid in rat primary cortical cultures (2004) (64)
- Neurotoxicity of heroin-cocaine combinations in rat cortical neurons. (2010) (63)
- Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress. (2013) (63)
- Activation of IGF-1 and Insulin Signaling Pathways Ameliorate Mitochondrial Function and Energy Metabolism in Huntington’s Disease Human Lymphoblasts (2015) (63)
- Aβ and NMDAR activation cause mitochondrial dysfunction involving ER calcium release (2015) (63)
- IGF-1 Intranasal Administration Rescues Huntington's Disease Phenotypes in YAC128 Mice (2014) (62)
- Mitochondrial-associated metabolic changes and neurodegeneration in Huntington's disease - from clinical features to the bench. (2010) (60)
- Mitochondria Control AMPA/Kainate Receptor-Induced Cytoplasmic Calcium Deregulation in Rat Cerebellar Granule Cells (2001) (59)
- Drugs of Abuse Induce Apoptotic Features in PC12 Cells (2003) (56)
- Oxidative Stress and Drugs of Abuse: An Update (2013) (55)
- Mitochondrial-dependent apoptosis in Huntington's disease human cybrids (2010) (55)
- Toxicity of β-amyloid in HEK293 cells expressing NR1/NR2A or NR1/NR2B N-methyl-d-aspartate receptor subunits (2007) (54)
- Glutathione redox cycle dysregulation in Huntington's disease knock-in striatal cells. (2012) (54)
- Bioenergetic dysfunction in Huntington's disease human cybrids (2011) (53)
- Influence of the antioxidants vitamin E and idebenone on retinal cell injury mediated by chemical ischemia, hypoglycemia, or oxidative stress. (1999) (53)
- Synthesis and cytotoxic profile of 3,4-methylenedioxymethamphetamine ("ecstasy") and its metabolites on undifferentiated PC12 cells: A putative structure-toxicity relationship. (2006) (51)
- The NAD+-dependent deacetylase SIRT2 attenuates oxidative stress and mitochondrial dysfunction and improves insulin sensitivity in hepatocytes (2017) (51)
- Effect of chronic exposure to aluminium on isoform expression and activity of rat (Na+/K+)ATPase. (2005) (44)
- Sirtuins: double players in Huntington's disease. (2015) (43)
- Histone Deacetylase Inhibitors Protect Against Pyruvate Dehydrogenase Dysfunction in Huntington's Disease (2017) (41)
- Bcl-2 overexpression protects against amyloid-beta and prion toxicity in GT1-7 neural cells. (2007) (40)
- Compromised mitochondrial complex II in models of Machado-Joseph disease. (2012) (38)
- Mitochondrial respiratory chain complex activity and bioenergetic alterations in human platelets derived from pre-symptomatic and symptomatic Huntington's disease carriers. (2013) (38)
- Adenosine Triphosphate Degradation Products After Oxidative Stress and Metabolic Dysfunction in Cultured Retinal Cells (1997) (37)
- Dual effect of lipid peroxidation on the membrane order of retinal cells in culture. (1995) (36)
- OXPHOS dysfunction regulates integrin-β1 modifications and enhances cell motility and migration. (2015) (34)
- BDNF regulates BIM expression levels in 3-nitropropionic acid-treated cortical neurons (2009) (34)
- Mitochondrial Ca2+ handling in Huntington's and Alzheimer's diseases - Role of ER-mitochondria crosstalk. (2017) (33)
- Microbial BMAA elicits mitochondrial dysfunction, innate immunity activation, and Alzheimer’s disease features in cortical neurons (2020) (33)
- Amyloid-beta peptide 1-42 causes microtubule deregulation through N-methyl-D-aspartate receptors in mature hippocampal cultures. (2012) (32)
- Mitochondrial SIRT3 confers neuroprotection in Huntington's disease by regulation of oxidative challenges and mitochondrial dynamics. (2020) (32)
- Oxidizing effects of exogenous stressors in Huntington's disease knock-in striatal cells--protective effect of cystamine and creatine. (2013) (32)
- IGF-1 protects against diabetic features in an in vivo model of Huntington's disease (2011) (31)
- Differential cytotoxic responses of PC12 cells chronically exposed to psychostimulants or to hydrogen peroxide. (2006) (30)
- Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells (2017) (30)
- BDNF and extracellular matrix regulate differentiation of mice neurosphere‐derived cells into a GABAergic neuronal phenotype (2009) (30)
- Insulin and IGF-1 regularize energy metabolites in neural cells expressing full-length mutant huntingtin (2016) (30)
- Caspase‐dependent and ‐independent cell death induced by 3‐nitropropionic acid in rat cortical neurons (2006) (30)
- Protective effect of zinc on amyloid-ß 25–35 and 1–40 mediated toxicity (2009) (29)
- FK506 ameliorates cell death features in Huntington’s disease striatal cell models (2011) (29)
- Amyloid β Peptide Compromises Neural Stem Cell Fate by Irreversibly Disturbing Mitochondrial Oxidative State and Blocking Mitochondrial Biogenesis and Dynamics (2018) (29)
- Apoptotic cell death induced by hydrogen peroxide in NT2 parental and mitochondrial DNA depleted cells (2004) (28)
- Chronic stress triggers divergent dendritic alterations in immature neurons of the adult hippocampus, depending on their ultimate terminal fields (2019) (27)
- Disruption of striatal glutamatergic/GABAergic homeostasis following acute methamphetamine in mice. (2012) (26)
- Impaired Src signaling and post-synaptic actin polymerization in Alzheimer's disease mice hippocampus — Linking NMDA receptors and the reelin pathway (2014) (26)
- Adenosine modulation of d-[3H]aspartate release in cultured retina cells exposed to oxidative stress (2000) (26)
- Protective effects of 3-alkyl luteolin derivatives are mediated by Nrf2 transcriptional activity and decreased oxidative stress in Huntington's disease mouse striatal cells (2015) (25)
- Valosin-Containing Protein (VCP/p97) Is an Activator of Wild-Type Ataxin-3 (2012) (25)
- Glutamate-mediated inhibition of oxidative phosphorylation in cultured retinal cells (2000) (24)
- Mitochondrial and metabolic-based protective strategies in Huntington’s disease: the case of creatine and coenzyme Q (2011) (24)
- Molecular targets and therapeutic strategies in Huntington's disease. (2005) (24)
- Mitochondrial apoptotic cell death and moderate superoxide generation upon selective activation of non‐desensitizing AMPA receptors in hippocampal cultures (2003) (23)
- Influence of vitamin E succinate on retinal cell survival. (1998) (23)
- Limited Effect of Chronic Valproic Acid Treatment in a Mouse Model of Machado-Joseph Disease (2015) (22)
- Overexpression of BDNF and Full-Length TrkB Receptor Ameliorate Striatal Neural Survival in Huntington's Disease (2015) (22)
- The Sigma-1 Receptor Mediates Pridopidine Rescue of Mitochondrial Function in Huntington Disease Models (2021) (22)
- Northeast Portuguese propolis protects against staurosporine and hydrogen peroxide-induced neurotoxicity in primary cortical neurons. (2011) (21)
- Oxidative stress in acidic conditions increases the production of inositol phosphates in chick retinal cells in culture. (1996) (20)
- Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases? (2017) (20)
- Mitochondrial and Redox Modifications in Huntington Disease Induced Pluripotent Stem Cells Rescued by CRISPR/Cas9 CAGs Targeting (2020) (20)
- Distinct Glycolysis Inhibitors Determine Retinal Cell Sensitivity to Glutamate-Mediated Injury (1999) (19)
- Interactions between neurons and glia in aging and disease (2007) (19)
- A whole brain longitudinal study in the YAC128 mouse model of Huntington’s disease shows distinct trajectories of neurochemical, structural connectivity and volumetric changes (2018) (18)
- Expression of NR1/NR2B N‐Methyl‐d‐Aspartate Receptors Enhances Heroin Toxicity in HEK293 Cells (2006) (17)
- Dysregulation of CREB Activation and Histone Acetylation in 3-Nitropropionic Acid-Treated Cortical Neurons: Prevention by BDNF and NGF (2010) (16)
- c-Src regulates Nrf2 activity through PKCδ after oxidant stimulus. (2019) (16)
- Influence of lipid peroxidation on [3H]ketanserin binding to 5-HT2 prefrontal cortex receptors (1995) (16)
- Dominant-Negative Effects of Adult-Onset Huntingtin Mutations Alter the Division of Human Embryonic Stem Cells-Derived Neural Cells (2016) (15)
- Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling (2021) (15)
- Chronic hyperglycemia impairs hippocampal neurogenesis and memory in an Alzheimer’s disease mouse model (2020) (14)
- Mitochondrial and Redox-Based Therapeutic Strategies in Huntington's Disease. (2020) (14)
- Protective effect of zinc on amyloid-beta 25-35 and 1-40 mediated toxicity. (2005) (14)
- Medical Toxicology of Drugs of Abuse (2013) (13)
- Modified Glutamatergic Postsynapse in Neurodegenerative Disorders (2019) (12)
- Adenosine A2A receptors regulate the extracellular accumulation of excitatory amino acids upon metabolic dysfunction in chick cultured retinal cells. (2000) (12)
- Developmental profile of excitatory GABAA responses in cultured rat cerebellar granule cells (2001) (12)
- Coriolus versicolor biomass increases dendritic arborization of newly-generated neurons in mouse hippocampal dentate gyrus (2018) (12)
- Cytotoxicity and Leishmanicidal Activity of Isoniazid-Derived Hydrazones and 2-Pyrazineformamide Thiosemicarbazones (2015) (11)
- Current therapeutic advances in patients and experimental models of Huntington's disease. (2014) (10)
- Disclosing the functional changes of two genetic alterations in a patient with Chronic Progressive External Ophthalmoplegia: Report of the novel mtDNA m.7486G>A variant (2017) (9)
- Antioxidant effect of flavonoids after ascorbate/Fe2+-induced oxidative stress in cultured retinal cells11Abbreviations: BME, basal medium of Eagle; DCFH2, 2′,7′-dichlorodihydrofluorescein; LDH, lactate dehydrogenase; PC, partition coefficient; Rf, retardation factor; ROS, reactive oxygen species; T (2001) (8)
- Mechanistic perspectives on differential mitochondrial-based neuroprotective effects of several carnitine forms in Alzheimer’s disease in vitro model (2021) (8)
- Calcium Signaling in Aging and Neurodegenerative Diseases 2019 (2020) (8)
- Mitochondrial function and dynamics in neural stem cells and neurogenesis: Implications for neurodegenerative diseases (2022) (7)
- Carvedilol protects ischemic cardiac mitochondria by preventing oxidative stress. (2004) (6)
- Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions (2021) (6)
- Alteration of nitric oxide synthase activity upon oxidative stress in cultured retinal cells. (1998) (6)
- Bcl‐2 Prevents Loss of Cell Viability and Caspase Activation Induced by 3‐Nitropropionic Acid in GT1‐7 Cells (2003) (6)
- Mitochondrial and redox modifications in early stages of Huntington's disease (2022) (6)
- Consequences of Mitochondrial Dysfunction in Huntington's Disease and Protection via Phosphorylation Pathways (2012) (5)
- Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein (2017) (5)
- Effect of Glucose Deprivation and Acute Glutamate Exposure in Cultured Retinal Cells (1998) (5)
- Alteration of nitric oxide synthase activity upon oxidative stress in cultured retinal cells (1998) (5)
- Neuroprotection of retinal ganglion cells by the sigma-1 receptor agonist pridopidine in models of experimental glaucoma (2021) (4)
- Polyglutamine Expansion Diseases – the Case of Machado-Joseph Disease (2007) (4)
- Boldine Attenuates Synaptic Failure and Mitochondrial Deregulation in Cellular Models of Alzheimer’s Disease (2021) (4)
- Mechanisms of neurodegeneration in Huntington’s disease (2008) (4)
- Revisiting cell and gene therapies in Huntington’s disease (2021) (3)
- Alpha-synuclein-induced oxidative stress correlates with altered superoxide dismutase and glutathione synthesis in human neuroblastoma SH-SY5Y cells (2016) (3)
- Defective mitochondria‐lysosomal axis enhances the release of extracellular vesicles containing mitochondrial DNA and proteins in Huntington's disease (2022) (3)
- Simultaneous Alteration of the Circadian Variation of Memory, Hippocampal Synaptic Plasticity, and Metabolism in a Triple Transgenic Mouse Model of Alzheimer’s Disease (2022) (3)
- MPV17 Mutations Are Associated With a Quiescent Energetic Metabolic Profile (2021) (3)
- Apoe4 and Alzheimer’s Disease Pathogenesis—Mitochondrial Deregulation and Targeted Therapeutic Strategies (2023) (2)
- Cocaine as a Neurotoxin (2021) (2)
- Defective mitochondrial-lysosomal axis promotes extracellular vesicles release of mitochondrial components in Huntington’s Disease (2022) (2)
- REVIEW ARTICLE Mechanisms of neurodegeneration in Huntington's disease (2008) (2)
- Characterization of subventricular zone-derived progenitor cells from mild and late symptomatic YAC128 mouse model of Huntington's disease. (2018) (2)
- Resveratrol and brain mitochondria (2021) (2)
- Developmental pro®le of excitatory GABAA responses in cultured rat cerebellar granule cells (1)
- Central and peripheral metabolic changes in neurodegenerative diseases. (2010) (1)
- Molecular Pathways of Mitochondrial Dysfunction in Neurodegeneration: the Paradigms of Parkinson's and Huntington's Diseases (2007) (1)
- Peripheral and cerebral metabolic features in an animal model of Huntington's disease (2010) (1)
- The spiritual well-being of the faculty of medicine and nursing (2015) (1)
- SIRT3, a modifier of mitochondrial function in Huntington's disease (2018) (1)
- Neuronal cell-based high-throughput screen for enhancers of mitochondrial function reveals luteolin as a modulator of mitochondria-endoplasmic reticulum coupling (2021) (1)
- Activation of IGF-1 and Insulin Signaling Pathways Ameliorate Mitochondrial Function and Energy Metabolism in Huntington’s Disease Human Lymphoblasts (2014) (1)
- Restored Fyn Levels in Huntington’s Disease Contributes to Enhanced Synaptic GluN2B-Composed NMDA Receptors and CREB Activity (2022) (1)
- Restoration of c-Src/Fyn proteins rescues mitochondrial dysfunction in Huntington's Disease. (2022) (1)
- Deficits of pyruvate dehydrogenase and mitochondrial dysfunction in Huntington's disease — role of histone deacetylase inhibitors (2014) (1)
- Glutamate regulates the viability of retinal cells in culture (2001) (1)
- Isolation and Maintenance of Murine Embryonic Striatal Neurons. (2018) (1)
- IGF-1 Intranasal Administration Rescues Huntington's Disease Phenotypes in YAC128 Mice (2013) (0)
- Mitochondria control NMDA receptor-dependent calcium rise evoked by amyloid-β 1-42 oligomers in rat cortical neurons (2011) (0)
- CORRIGENDUM REVIEW of neurodegeneration in Huntington's disease (2008) (0)
- Influence of reactive oxygen species and glutamate on the cytotoxicity of cultured retinal cells : a model of neuronal ischaemia (1999) (0)
- Girao H, Wong LJC, Taylor RW, Grazina M. Disclosing the functional changes of two genetic alterations in a patient with Chronic Progressive External Ophthalmoplegia: Report of the novel mtDNA m.7486G>A (2018) (0)
- Amyloid β Peptide Compromises Neural Stem Cell Fate by Irreversibly Disturbing Mitochondrial Oxidative State and Blocking Mitochondrial Biogenesis and Dynamics (2018) (0)
- Influence of gamma-aminobutyric acid on retinal cells excitotoxicity upon glucose deprivation. (1999) (0)
- Postsynaptic decrease of SAPAP3 scaffold protein in Huntington’s disease (2019) (0)
- P3.011 Alpha-synuclein phosphorylation mediated by iron and rotenone in a cellular model of Parkinson's disease (2009) (0)
- INJURY MARKERS IN PERIPHERAL BLOOD MONONUCLEAR CELLS FROM MILD COGNITIVE IMPAIRMENT AND ALZHEIMER ' S DISEASE PATIENTS (2011) (0)
- Neurotoxicity of cocaine (2012) (0)
- Adaptation to oxidative stress in the chronic effects of cocaine and amphetamine (2007) (0)
- Expanded and Wild-type Ataxin-3 Modify the Redox Status of SH-SY5Y Cells Overexpressing α-Synuclein (2017) (0)
- Comparative Mitochondrial-Based Protective Effects of Resveratrol and Nicotinamide in Huntington’s Disease Models (2016) (0)
- Influence of γ-aminobutyric acid on retinal cells excitotoxicity upon glucose deprivation (1999) (0)
- I13 Pridopidine restores mitochondrial function and decreases er stress which is mediated through the S1R (2021) (0)
- Extracellular vesicles improve GABAergic transmission in Huntington’s disease iPSC-derived neurons (2022) (0)
- Mitochondrial and Redox Changes in Periodontitis and Type 2 Diabetes Human Blood Mononuclear Cells (2023) (0)
- Impact of SAPAP3 on mitochondrial function in Huntington’s disease (2021) (0)
- C05 SAPAP3 scaffolding protein as a regulator of mitochondrial function in huntington’s disease (2021) (0)
- INCREASED BRAIN LEVELS OF HYDROGEN PEROXIDE IN A TRANSGENIC MOUSE MODEL OF HUNTINGTON ’ S DISEASE (2015) (0)
- Microbial BMAA elicits mitochondrial dysfunction, innate immunity activation, and Alzheimer’s disease features in cortical neurons (2020) (0)
- ROLE OF INSULIN AND IGF-1 IN ENERGY METABOLISM IN HUNTINGTON’S DISEASE: STUDIES IN CORTICAL AND STRIATAL NEURONS FROM YAC128 TRANSGENIC MICE AND HUMAN LYMPHOBLASTS (2010) (0)
- Revisiting Mitochondrial Function and Metabolism in Pluripotent Stem Cells: Where Do We Stand in Neurological Diseases? (2016) (0)
- Northeast Portuguese propolis protects against neurotoxic events in cerebral cortical neurons (2010) (0)
- Heroin-induced degeneration of cortical neurons involves mitochondria-dependent apoptosis (2005) (0)
This paper list is powered by the following services:
Other Resources About Ana Cristina Rego
What Schools Are Affiliated With Ana Cristina Rego?
Ana Cristina Rego is affiliated with the following schools:
